Study examined circulating tumour DNA as a biomarker in DLBCL.
Home / Resource Library / Tissue-Matched IgH Gene Rearrangement of Circulating Tumor DNA Shows Significant Value in Predicting the Progression of Diffuse Large B Cell Lymphoma
Study examined circulating tumour DNA as a biomarker in DLBCL.